Summary: Cholesterol drug alirocumab was linked to a 15% lower risk of dying in a new study released Saturday. [This article first appeared on LongevityFacts. Author: Brady Hartman. ]
The cholesterol-lowering drug alirocumab was linked to a 15% lower risk of death, and an equivalent reduction of cardiovascular events, such as heart attack and stroke, according to a new study.
It’s the first time a cholesterol-lowering drug has reduced deaths since statins such as Crestor and Lipitor came out decades ago.
Read more
Comments are closed.